Tenet Healthcare price target raised to $230 from $225 at BofA

BofA raised the firm’s price target on Tenet Healthcare (THC) to $230 from $225 and keeps a Buy rating on the shares. BofA views the increase in capital expenditures as a bullish sign of Tenet’s view on demand in its markets, given it is happening in front of enrollment pressures on exchanges and Medicaid, the analyst tells investors in a research note.